Redesigning channel-forming peptides: amino acid substitutions that enhance rates of supramolecular self-assembly and raise ion transport activity |
| |
Authors: | Shank Lalida P Broughman James R Takeguchi Wade Cook Gabriel Robbins Ashley S Hahn Lindsey Radke Gary Iwamoto Takeo Schultz Bruce D Tomich John M |
| |
Affiliation: | Department of Biochemistry, and Department of Anatomy and Physiology, Kansas State University, Manhattan, Kansas 66506, USA. |
| |
Abstract: | ![]() Three series of 22-residue peptides derived from the transmembrane M2 segment of the glycine receptor alpha1-subunit (M2GlyR) have been designed, synthesized, and tested to determine the plasticity of a channel-forming sequence and to define whether channel pores with enhanced conductive properties could be created. Sixteen sequences were examined for aqueous solubility, solution-association tendency, secondary structure, and half-maximal concentration for supramolecular assembly, channel activity, and ion transport properties across epithelial monolayers. All peptides interact strongly with membranes: associating with, inserting across, and assembling to form homooligomeric bundles when in micromolar concentrations. Single and double amino acid replacements involving arginine and/or aromatic amino acids within the final five C-terminal residues of the peptide cause dramatic effects on the concentration dependence, yielding a range of K1/2 values from 36 +/- 5 to 390 +/- 220 microM for transport activity. New water/lipid interfacial boundaries were established for the transmembrane segment using charged or aromatic amino acids, thus limiting the peptides' ability to move perpendicularly to the plane of the bilayer. Formation of discrete water/lipid interfacial boundaries appears to be necessary for efficient supramolecular assembly and high anion transport activity. A peptide sequence is identified that may show efficacy in channel replacement therapy for channelopathies such as cystic fibrosis. |
| |
Keywords: | CF, cystic fibrosis WT, wild type TFE, 2,2,2-trifluoroethanol 1-EBIO, 1-ethyl-2-benzimidazolinone M2GlyR, second transmembrane sequence of the α1 subunit of the glycine receptor from spinal cord TM, transmembrane MDCK, Madin-Darby canine kidney cells Isc, short circuit current NMR, nuclear magnetic resonance MW, molecular weight FMOC, 9-fluorenylmethoxycarbonyl HMP, p-hydroxymethyl-phenoxymethyl HPLC, high performance liquid chromatography TFA, trifluoroacetic acid CD, circular dichroism MALDI-TOF, matrix assisted-laser absorption time of flight mass spectroscopy DI, deionized BS3, Bis [sulfosuccinimidyl] suberate HEPES, 4-(2-hydroxyethyl) piperazine-1-ethanesulfonic acid NMDG Cl, N-methyl-D-glucosamine-Cl EDTA, ethylenediamine-tetracetic acid SDS, sodium dodecylsulfate PAGE, polyacrylamide gel electrophoresis POPC, (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) POPG, (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-(1-glycerol)) |
本文献已被 ScienceDirect PubMed 等数据库收录! |
|